Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated
Neurology

Neurodevelopmental disorder with seizures and gingival overgrowth: A Patient Guide

At a Glance

NEDSGO is an ultra-rare genetic condition caused by changes in both copies of TBC1D2B. It can lead to developmental delay, epilepsy, and gingival overgrowth, so care combines genetic confirmation, seizure treatment, oral-health support, developmental therapies, and ongoing monitoring.

Neurodevelopmental disorder with seizures and gingival overgrowth (NEDSGO) is an ultra-rare genetic condition that primarily affects the brain’s development and the growth of certain oral tissues. It is caused by changes (variants) in both copies of the TBC1D2B gene, which normally helps manage how cells transport materials and recycle waste [1][2]. Because the condition follows an autosomal recessive inheritance pattern, it typically occurs when a child inherits one changed gene from each parent [3]. For most families, this diagnosis comes at the end of a long “diagnostic odyssey,” as there are fewer than 15 cases reported in medical literature worldwide [4][2].

Living with NEDSGO generally involves managing a “triad” of core symptoms: developmental delay, seizures, and gingival overgrowth. In the reported individuals, most children experience delays in reaching milestones like walking or speaking, and approximately 8 out of 10 develop some form of epilepsy [2]. The gingival overgrowth—a thickening of the soft gum tissue—often begins in early childhood and can sometimes be accompanied by distinct changes in the jawbone known as fibrous dysplasia [3][4]. While these symptoms vary significantly between children, having a precise genetic name for the condition allows your care team to move away from searching for a cause and toward proactive, targeted management [1].

A central focus of care for NEDSGO is the coordination between neurology and dentistry. Because some common seizure medications, such as phenytoin, are known to worsen gum overgrowth, your doctors must work together to choose treatments that balance seizure control with oral health according to your child’s specific seizure type [5][2]. For some children, the condition has been reported to be progressive, meaning that skills or physical stability may change over time [3]. Clinical monitoring through symptom-based physical examinations, developmental assessments, and targeted imaging helps catch these changes early and adjust therapies to support your child’s quality of life [4][2].

While the rarity of NEDSGO means there is much that remains uncertain, your role as a parent and advocate is the foundation of your child’s care. By building a team of specialists—including neurologists, dentists, and therapists—who are willing to collaborate and learn alongside you, you can create a management plan tailored to your child’s unique needs [6][7]. Although the journey with an ultra-rare disease is complex, a molecular diagnosis provides the map needed to navigate the challenges and focus on your child’s growth and daily well-being [8].

Common questions in this guide

What is NEDSGO?
NEDSGO is an ultra-rare genetic condition involving brain development and oral tissues. It is caused by disease-causing variants in both copies of the TBC1D2B gene and commonly involves developmental delay, seizures, and gingival overgrowth.
What does a TBC1D2B genetic test show in NEDSGO?
A genetic diagnosis is supported when testing finds disease-causing or likely disease-causing variants in both copies of TBC1D2B. A genetics professional can explain how the laboratory classified each variant and what the result may mean for relatives.
What symptoms are associated with NEDSGO?
The main features are delayed development, seizures or epilepsy, and thickened gum tissue called gingival overgrowth. Some children also have fibrous dysplasia of the jaw, and the severity and combination of features can vary.
Can seizure medicine make gingival overgrowth worse?
Yes. Phenytoin is a seizure medicine that can worsen gingival overgrowth in some people, so the neurologist and dentist should consider oral health when reviewing treatment. Do not stop or change a seizure medicine without the prescribing clinician.
How will doctors monitor my child’s NEDSGO over time?
Monitoring may include physical examinations, developmental and neurologic assessments, and targeted imaging when needed. These evaluations can help identify changes in skills, physical stability, or the bones and brain so the care plan can be adjusted.
Who should coordinate care for a child with NEDSGO?
Care often involves a neurologist, dentist, genetics professional, and therapists. Ask the team to name a lead clinician who can coordinate appointments, medication decisions, developmental support, and communication between specialists.
Can NEDSGO get worse over time?
Some reported children have had progressive changes, including changes in skills or physical stability, but the course varies and remains uncertain because the condition is so rare. Regular developmental and clinical monitoring helps the team respond to new concerns.

Get notified when new evidence is published on neurodevelopmental disorder with seizures and gingival overgrowth.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Biallelic loss-of-function variants in TBC1D2B cause a neurodevelopmental disorder with seizures and gingival overgrowth.

    Harms FL, Parthasarathy P, Zorndt D, et al.

    Human mutation 2020; (41(9)):1645-1661 doi:10.1002/humu.24071.

    PMID: 32623794
  2. 2

    Loss of TBC1D2B causes a progressive neurological disorder with gingival overgrowth.

    Harms FL, Rexach JE, Efthymiou S, et al.

    European journal of human genetics : EJHG 2024; (32(5)):558-566 doi:10.1038/s41431-024-01563-5.

    PMID: 38374468
  3. 3

    Biallelic frameshift variant in the TBC1D2B gene in two siblings with progressive gingival overgrowth, fibrous dysplasia of face, and mental deterioration.

    Correia-Costa GR, de Leeuw N, Pfundt R, et al.

    Clinical genetics 2022; (102(6)):537-542 doi:10.1111/cge.14215.

    PMID: 36029130
  4. 4

    A Novel Homozygous TBC1D2B Variant Disrupts Functional Domains and Suggests Impaired Rab-GTPase Regulation in Neurodevelopmental Disorder.

    Ozturk M, Arslan CB, Akbulut E, et al.

    Developmental neurobiology 2025; (85(4)):e22998 doi:10.1002/dneu.22998.

    PMID: 40898781
  5. 5

    Periodontal Management to Improve Oral Health-related Quality of Life in an Adolescent Girl with Phenytoin-induced Gingival Enlargement: A Case Report.

    Dawar A, Gumber B, Makker K

    International journal of clinical pediatric dentistry 2025; (18(5)):599-605 doi:10.5005/jp-journals-10005-3133.

    PMID: 41050299
  6. 6

    Beyond seizures: the hidden burden of developmental epileptic encephalopathies.

    Dell'Isola GB, Sorrentino M, Massara S, et al.

    Frontiers in neurology 2026; (17()):1960314 doi:10.3389/fneur.2026.1960314.

    PMID: 42953089
  7. 7

    Needs of children with neurodevelopmental disorders and medical complexity: Caregiver perspectives.

    Materula D, Currie G, Jia XY, et al.

    Research in developmental disabilities 2024; (153()):104815 doi:10.1016/j.ridd.2024.104815.

    PMID: 39142086
  8. 8

    Exploring Parents' Values in Healthcare Decision-Making for Rare Genetic Neurodevelopmental Disorders: A Qualitative Study to Inform Guideline Development.

    Klein Haneveld MJ, Cox L, Embregts PJCM, et al.

    Journal of intellectual disability research : JIDR 2026; (70(9)):913-922 doi:10.1111/jir.70150.

    PMID: 42571921

This NEDSGO page is for informational purposes only and does not constitute medical advice. Your child’s neurologist, dentist, genetics specialist, and therapy team can interpret the diagnosis and tailor seizure, oral-health, and developmental care.